 |
Cisplatin/epinephrine |
|---|---|
| Trade Name | Intradose |
| Orphan Indication | Squamous cell carcinoma of the head and neck |
| USA Market Approval | USA |
| USA Designation Date | 2000-04-03 00:00:00 |
| Sponsor | Matrix Pharmaceutical, Inc.;34700 Campus Drive;Fremont, California, 94555 |
